These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29779801)

  • 1. Docosahexaenoic acid supplementation for children with attention deficit hyperactivity disorder: A comprehensive review of the evidence.
    Ramalho R; Pereira AC; Vicente F; Pereira P
    Clin Nutr ESPEN; 2018 Jun; 25():1-7. PubMed ID: 29779801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and cognitive effects of docosahexaenoic acid in drug-naïve children with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled clinical trial.
    Crippa A; Tesei A; Sangiorgio F; Salandi A; Trabattoni S; Grazioli S; Agostoni C; Molteni M; Nobile M
    Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):571-583. PubMed ID: 30246216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study.
    Huss M; Völp A; Stauss-Grabo M
    Lipids Health Dis; 2010 Sep; 9():105. PubMed ID: 20868469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early monitoring of fatty acid profile in children with attention deficit and/or hyperactivity disorder under treatment with omega-3 polyunsaturated fatty acids.
    Checa-Ros A; Haro-García A; Seiquer I; Molina-Carballo A; Uberos-Fernández J; Muñoz-Hoyos A
    Minerva Pediatr; 2019 Aug; 71(4):313-325. PubMed ID: 30419741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of supplementation with long-chain ω-3 polyunsaturated fatty acids on behavior and cognition in children with attention deficit/hyperactivity disorder (ADHD): a randomized placebo-controlled intervention trial.
    Widenhorn-Müller K; Schwanda S; Scholz E; Spitzer M; Bode H
    Prostaglandins Leukot Essent Fatty Acids; 2014; 91(1-2):49-60. PubMed ID: 24958525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066.
    Kean JD; Camfield D; Sarris J; Kras M; Silberstein R; Scholey A; Stough C
    Nutr J; 2013 Jul; 12():100. PubMed ID: 23866813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Erythrocyte Eicosapentaenoic Acid and Docosahexaenoic Acid Are Associated With Improved Attention and Behavior in Children With ADHD in a Randomized Controlled Three-Way Crossover Trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    J Atten Disord; 2015 Nov; 19(11):954-64. PubMed ID: 24214970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eicosapentaenoic and docosahexaenoic acids, cognition, and behavior in children with attention-deficit/hyperactivity disorder: a randomized controlled trial.
    Milte CM; Parletta N; Buckley JD; Coates AM; Young RM; Howe PR
    Nutrition; 2012 Jun; 28(6):670-7. PubMed ID: 22541055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of dietary supplementation with natural ω-3 polyunsaturated fatty acids on the visual acuity of school-age children with lower IQ or attention-deficit hyperactivity disorder.
    Wu Q; Zhou T; Ma L; Yuan D; Peng Y
    Nutrition; 2015; 31(7-8):935-40. PubMed ID: 26015389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.
    Colter AL; Cutler C; Meckling KA
    Nutr J; 2008 Feb; 7():8. PubMed ID: 18275609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.
    Matsudaira T; Gow RV; Kelly J; Murphy C; Potts L; Sumich A; Ghebremeskel K; Crawford MA; Taylor E
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):775-82. PubMed ID: 26682998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of Attention-Deficit/Hyperactivity Disorders with polyunsaturated fatty acids - an effective treatment alternative?].
    Frölich J; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2008 Mar; 36(2):109-16. PubMed ID: 18622940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supplementation with polyunsaturated fatty acids (PUFAs) in the management of attention deficit hyperactivity disorder (ADHD).
    Banaschewski T; Belsham B; Bloch MH; Ferrin M; Johnson M; Kustow J; Robinson S; Zuddas A
    Nutr Health; 2018 Dec; 24(4):279-284. PubMed ID: 29921155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-3 fatty acids are inversely related to callous and unemotional traits in adolescent boys with attention deficit hyperactivity disorder.
    Gow RV; Vallee-Tourangeau F; Crawford MA; Taylor E; Ghebremeskel K; Bueno AA; Hibbeln JR; Sumich A; Rubia K
    Prostaglandins Leukot Essent Fatty Acids; 2013 Jun; 88(6):411-8. PubMed ID: 23664595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary PUFA intakes in children with attention-deficit/hyperactivity disorder symptoms.
    Ng KH; Meyer BJ; Reece L; Sinn N
    Br J Nutr; 2009 Dec; 102(11):1635-41. PubMed ID: 19631022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.
    Lange KW; Hauser J; Lange KM; Makulska-Gertruda E; Nakamura Y; Reissmann A; Sakaue Y; Takano T; Takeuchi Y
    Curr Psychiatry Rep; 2017 Feb; 19(2):8. PubMed ID: 28168597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms.
    López-Vicente M; Ribas Fitó N; Vilor-Tejedor N; Garcia-Esteban R; Fernández-Barrés S; Dadvand P; Murcia M; Rebagliato M; Ibarluzea J; Lertxundi A; Fernández-Somoano A; Tardón A; López-Sabater MC; Romaguera D; Vrijheid M; Sunyer J; Julvez J
    J Pediatr; 2019 Jun; 209():204-211.e4. PubMed ID: 30929929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.